MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) signed a binding letter of intent (LOI) to acquire SKNY Pharmaceuticals, Inc. The ...

To produce cannabinoids in yeast (Saccharomyces cerevisiae), UC Berkeley synthetic biologists first engineered yeast's native mevalonate pathway to provide a high flux of geranyl pyrophosphate ...

also plays a role in the regulation of the cannabinoid pathway. Consistent with this, Di Marzo et al found that obese db/db and ob/ob mice, ...

Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body’s natural pain-killing pathway without evoking drug tolerance or psychoactivity. Read the paper ...

These edibles are pushing the boundaries of what consumers expect, offering a discreet and accessible alternative to ...

Researchers are attempting to spread awareness about that condition, cannabinoid hyperemesis syndrome (CHS), and the need for more government oversight in the legal cannabis industry. A rare but ...

Journavx's main ingredient works by targeting a pain-signaling pathway that involves sodium channels in the ... but still enough to dampen its potential as a pain treatment. He said a synthetic ...

Health Canada recently announced that it is exploring a regulatory pathway that would allow products containing cannabidiol ( ...

Journavx's main ingredient works by targeting a pain-signaling pathway that involves sodium ... He said a synthetic cannabinoid molecule that avoids binding to the high-producing CB1 nerve cell ...